Thomas Ulich
2014
In 2014, Thomas Ulich earned a total compensation of $1.3M as Chief Scientific Officer at InVivo Therapeutics Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $52,500 |
|---|---|
| Option Awards | $1,015,924 |
| Salary | $201,231 |
| Stock Awards | $22,500 |
| Other | $47,431 |
| Total | $1,339,586 |
Ulich received $1M in option awards, accounting for 76% of the total pay in 2014.
Ulich also received $52.5K in non-equity incentive plan, $201.2K in salary, $22.5K in stock awards and $47.4K in other compensation.
Rankings
In 2014, Thomas Ulich's compensation ranked 6,284th out of 13,032 executives tracked by ExecPay. In other words, Ulich earned more than 51.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,284 out of 13,032 | 52nd |
Division Manufacturing | 2,289 out of 4,965 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 280 out of 731 | 62nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 151 out of 441 | 66th |
Industry Surgical and Medical Instruments and Apparatus | 81 out of 270 | 70th |
Source: SEC filing on April 25, 2017.
Ulich's colleagues
We found four more compensation records of executives who worked with Thomas Ulich at InVivo Therapeutics Holdings in 2014.